Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06FQU
|
|||
Drug Name |
INCB53914
|
|||
Indication | Advanced malignancy [ICD-11: 2A00-2F9Z; ICD-10: C00-C96; ICD-9: 140-229] | Phase 1/2 | [1] | |
Company |
Incyte Wilmington, DE
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Serine/threonine-protein kinase pim (PIM) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.